Overview

Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis

Status:
Completed
Trial end date:
2007-07-31
Target enrollment:
Participant gender:
Summary
Comparison of lower dosage etoricoxib (60 mg daily) with aceclofenac (100 mg bid) for their efficacy and safety in the treatment of rheumatoid arthritis (RA).
Phase:
Phase 4
Details
Lead Sponsor:
Chung Shan Medical University
Treatments:
Aceclofenac
Diclofenac
Etoricoxib